Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 1/2010

01-01-2010 | Case Report

Reversible vestibular dysfunction secondary to sotalol use

Authors: Suraj Kapa, Jill J. Nagel, Arshad Jahangir, Samuel J. Asirvatham

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2010

Login to get access

Excerpt

Cellular responses to stimuli in multiple areas of the human body are dependent on maintenance of normal transmembrane electrical gradients, largely mediated by channels that control intra- and extra-cellular sodium, potassium, and calcium concentrations. Thus, dysfunction of the channels responsible for electrolyte influx and efflux may cause an array of symptoms in otherwise disparate organ systems. For example, patients with cardiac channelopathies such as long QT syndrome have been reported to develop dysfunction of the auditory/vestibular apparatus (Jervell and Lange-Nielsen Syndrome) [1] as well as gastrointestinal symptoms [2]. Thus, it is possible that antiarrhythmics, whose therapeutic effects are realized by direct effects on the function of sodium and potassium channels, may have secondary effects on normal function in other organs. In particular, the potassium channel plays a prominent role in maintaining normal auditory and vestibular function [3]. While sotalol is known to cause lightheadedness in as many as 12%, dizziness in as many as 20% of patients [4], and has been rarely (<1/10,000) associated with vertigo as well [5, 6], pathologic effects on vestibular function have not been reported. We report a case of reversible vestibular dysfunction secondary to sotalol use that, to our knowledge, has not previously been recognized. …
Literature
1.
go back to reference Jervell, A., & Lange-Nielsen, F. (1957). Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. American Heart Journal, 54, 59–68.CrossRefPubMed Jervell, A., & Lange-Nielsen, F. (1957). Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. American Heart Journal, 54, 59–68.CrossRefPubMed
2.
go back to reference Locke, G. R., 3rd, Ackerman, M. J., Zinsmeister, A. R., Thapa, P., & Farrugia, G. (2006). Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy. American Journal of Gastroenterology, 101, 1299–1304.CrossRefPubMed Locke, G. R., 3rd, Ackerman, M. J., Zinsmeister, A. R., Thapa, P., & Farrugia, G. (2006). Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy. American Journal of Gastroenterology, 101, 1299–1304.CrossRefPubMed
3.
go back to reference Wangemann, P. (2002). K + cycling and the endocochlear potential. Hearing Research, 165, 1–9.CrossRefPubMed Wangemann, P. (2002). K + cycling and the endocochlear potential. Hearing Research, 165, 1–9.CrossRefPubMed
4.
go back to reference Information, P. (2007). BETAPACE AF(R) oral tablets, sotalol hcl oral tablets. Wayne, NJ: Bayer Healthcare Pharmaceuticals, Inc. Information, P. (2007). BETAPACE AF(R) oral tablets, sotalol hcl oral tablets. Wayne, NJ: Bayer Healthcare Pharmaceuticals, Inc.
5.
go back to reference Reynaert, J. (1979). Once-a-day treatment with sotalol and hydrochlorothiazide in patients with essential hypertension. Journal of Clinical Pharmacology, 19, 579–583.PubMed Reynaert, J. (1979). Once-a-day treatment with sotalol and hydrochlorothiazide in patients with essential hypertension. Journal of Clinical Pharmacology, 19, 579–583.PubMed
6.
go back to reference Product Monograph: pms-Sotalol (Sotalol Hydrochloride Tablets BP). 80 mg, 160 mg and 240 mg. PharmaScience Inc., Montreal Canada, 30 June 1998. Product Monograph: pms-Sotalol (Sotalol Hydrochloride Tablets BP). 80 mg, 160 mg and 240 mg. PharmaScience Inc., Montreal Canada, 30 June 1998.
7.
go back to reference Visser, J. E., Carpenter, M. G., van der Koolj, H., & Bloem, B. R. (2008). The clinical utility of posturography. Clinical Neurophysiology, 119, 2424–2436.CrossRefPubMed Visser, J. E., Carpenter, M. G., van der Koolj, H., & Bloem, B. R. (2008). The clinical utility of posturography. Clinical Neurophysiology, 119, 2424–2436.CrossRefPubMed
8.
go back to reference Wall, C., 3rd. (1990). The sinusoidal harmonic acceleration rotary chair test. Theoretical and clinical basis. Neurologic Clinics, 8, 269–285.PubMed Wall, C., 3rd. (1990). The sinusoidal harmonic acceleration rotary chair test. Theoretical and clinical basis. Neurologic Clinics, 8, 269–285.PubMed
9.
go back to reference Magnan, J., Chays, A., & Ulmer, E. (1994). Videonystagmography: new technology for the functional investigation of vertigo. In R. Filipo & M. Barbara (Eds.), Proceedings of the Third International Symposium on Ménière’s Disease (pp. 371–374). Amsterdam: Kugler Publications. Magnan, J., Chays, A., & Ulmer, E. (1994). Videonystagmography: new technology for the functional investigation of vertigo. In R. Filipo & M. Barbara (Eds.), Proceedings of the Third International Symposium on Ménière’s Disease (pp. 371–374). Amsterdam: Kugler Publications.
10.
go back to reference Ferber-Viart, C., Dubreuil, C., & Duclaux, R. (1999). Vestibular evoked myogenic potentials in humans: a review. Acta Oto-Laryngologica, 119, 6–15.PubMed Ferber-Viart, C., Dubreuil, C., & Duclaux, R. (1999). Vestibular evoked myogenic potentials in humans: a review. Acta Oto-Laryngologica, 119, 6–15.PubMed
11.
go back to reference Colatski, T. J., Follmer, C. H., & Starmer, C. F. (1990). Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation, 82, 2235–2242. Colatski, T. J., Follmer, C. H., & Starmer, C. F. (1990). Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation, 82, 2235–2242.
12.
go back to reference Grissmer, S., Nguyen, A. N., Aiyar, J., Hanson, D. C., Mather, R. J., Gutman, G. A., et al. (1994). Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Molecular Pharmacology, 45, 1227–1234.PubMed Grissmer, S., Nguyen, A. N., Aiyar, J., Hanson, D. C., Mather, R. J., Gutman, G. A., et al. (1994). Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Molecular Pharmacology, 45, 1227–1234.PubMed
13.
go back to reference Numaguchi, H., Mullins, F. M., Johnson, J. P., John, D. C., Po, S. S., Yang, I. C. H., et al. (2000). Probing the interaction between inactivation gating and D-sotalol block of HERG. Circulation Research, 87, 1012–1018.PubMed Numaguchi, H., Mullins, F. M., Johnson, J. P., John, D. C., Po, S. S., Yang, I. C. H., et al. (2000). Probing the interaction between inactivation gating and D-sotalol block of HERG. Circulation Research, 87, 1012–1018.PubMed
14.
go back to reference Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., et al. (1999). MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell, 97, 175–187.CrossRefPubMed Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., et al. (1999). MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell, 97, 175–187.CrossRefPubMed
15.
go back to reference Pessia, M., Servettini, I., Panichi, R., Guasti, L., Grassi, S., Arcangeli, A., et al. (2008). ERG voltage-gated K+ channels regular excitability and discharge dynamics of the medial vestibular nucleus neurones. Journal of Physiology, 586, 4877–4890.CrossRefPubMed Pessia, M., Servettini, I., Panichi, R., Guasti, L., Grassi, S., Arcangeli, A., et al. (2008). ERG voltage-gated K+ channels regular excitability and discharge dynamics of the medial vestibular nucleus neurones. Journal of Physiology, 586, 4877–4890.CrossRefPubMed
16.
go back to reference de Castro, M. P., Aranega, A., & Franco, D. (2006). Protein distribution of KCNQ1, KCNH2 and KCNE3 potassium channel subunits during mouse embryonic development. The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 288, 304–315.CrossRef de Castro, M. P., Aranega, A., & Franco, D. (2006). Protein distribution of KCNQ1, KCNH2 and KCNE3 potassium channel subunits during mouse embryonic development. The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 288, 304–315.CrossRef
17.
go back to reference Gabashvili, I. S., Sokolowski, B. H. A., Morton, C. C., & Giersch, A. B. S. (2007). Ion channel gene expression in the inner ear. Journal of the Association for Research in Otolaryngology, 8, 305–328.CrossRefPubMed Gabashvili, I. S., Sokolowski, B. H. A., Morton, C. C., & Giersch, A. B. S. (2007). Ion channel gene expression in the inner ear. Journal of the Association for Research in Otolaryngology, 8, 305–328.CrossRefPubMed
18.
go back to reference Schwartz, P. J., Spazzolini, C., Crotti, L., Bathen, J., Amlie, J. P., Timothy, K., et al. (2006). The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation, 113, 783–790.CrossRefPubMed Schwartz, P. J., Spazzolini, C., Crotti, L., Bathen, J., Amlie, J. P., Timothy, K., et al. (2006). The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation, 113, 783–790.CrossRefPubMed
19.
go back to reference Arbusow, V., Strupp, M., & Brandt, T. (1998). Amiodarone-induced severe prolonged head-positional vertigo and vomiting. Neurology, 51, 917.PubMed Arbusow, V., Strupp, M., & Brandt, T. (1998). Amiodarone-induced severe prolonged head-positional vertigo and vomiting. Neurology, 51, 917.PubMed
Metadata
Title
Reversible vestibular dysfunction secondary to sotalol use
Authors
Suraj Kapa
Jill J. Nagel
Arshad Jahangir
Samuel J. Asirvatham
Publication date
01-01-2010
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 1/2010
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-009-9441-4

Other articles of this Issue 1/2010

Journal of Interventional Cardiac Electrophysiology 1/2010 Go to the issue